Advancing Alternatives Inc.

Private Company, Headquarters Location
717 Schuylkill Mountain Rd., Schuylkill Haven, PA 17972, United States
(877)546-2257, (570)739-1034, (570)739-1258 fax, http://www.advancingalternatives.com

Primary SIC: Hardware, Not Elsewhere Classified, Primary NAICS: Hardware Manufacturing
Description: Hardware, Not Elsewhere Classified

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Advancing Alternatives Inc., News and Information

Steven R. Goldstein, M.D., Joins Bionovo's Menerba Medical Advisory Board.
Cancer Weekly; 11/17/2009; 791 words; Bionovo, Inc. (NASDAQ: BNVI...advisory board as we are advancing Menerba™ to...uterine cancer; therefore alternative therapies are desperately...and "The Estrogen Alternative." He is one of the...s Health, Bionovo Inc. This article was prepared...

Evergreen Energy, Inc. Selected for Feasibility Study With Shanghai Electric Power Company Ltd.
China Weekly News; 11/17/2009; 1209 words; Evergreen Energy Inc. (NYSE Arca:EEE...C-Lock Technology, Inc. has been selected by...while at the same time advancing U.S. commercial interests...About Evergreen Energy Inc. Evergreen Energy Inc...Energy Inc., Energy, Alternative Energy, Coal, Greenhouse...

Cyto Pulse, the Karolinska Hospital/Institutet and SMI Receive Approval from the Swedish Medical Products Agency to Start a Clinical Trial Evaluating a CEA-based Vaccine in Patients with Colorectal Cancer.
Cancer Gene Therapy Week; 11/16/2009; 1201 words; ...Cyto Pulse Sciences, Inc.). Britta Wahren...been instrumental in advancing Derma Vax™...Cyto Pulse Sciences, Inc. is a biomedical device...Keywords: , Energy, Alternative Energy, Health, Biotechnology...Cyto Pulse Sciences Inc. This article was prepared...

Prudential Community Resources awards $110,000 To winners of the Strength for Capacity business plan competition.(Company overview)
Business Wire; 11/12/2009; 1460 words; ...Department of Prudential Financial, Inc. (NYSE:PRU) to encourage nonprofits...board and staff leaders information about alternatives to traditional events-based fundraising...award will help us take the next steps in advancing our business strategy when we launch...

AcelRx Announces Successful Completion of End-of-Phase 2 Meeting on ARX-01, Sufentanil NanoTab PCA System for Post-Operative Pain Management.(Clinical report)
Blood Weekly; 11/12/2009; 1132 words; ...AcelRx Pharmaceuticals, Inc. announced that it has...offers a non-invasive alternative to intravenous patient...operative complications and advancing recovery. Furthermore...AcelRx Pharmaceuticals, Inc.). The ARX-01 Sufentanil...AcelRx Pharmaceuticals, Inc. AcelRx Pharmaceuticals...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.